Get the content you want anytime you want.
REGISTER NOW | SIGN IN

The Contagion® Healthcare Associated Infections (HAI) specialty page provides HAI-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

C. DIFFICILE NEWS - Page 3

Fidaxomicin Vs. Vancomycin: What's More Effective for Treating <i>C. difficile?</i>
A recent study compares the effectiveness of a novel fidaxomicin therapy with vancomycin for the treatment of C. difficile.
Top Infectious Disease News of the Week—January 7, 2018
In case you missed them, we've compiled the top 5 articles from this past week.
Metronidazole vs Vancomycin in Mild <i>Clostridium difficile</i> Infections
Lawrence J. Brandt, MD; Erik Dubberke, MD; Daniel E. Freedberg, MD, MS; Dale N. Gerding, MD; Yoav Golan, MD, MS; and Peter L. Salgo, MD, discuss provider considerations when making decisions on how to treat patients with Clostridium difficile with the guideline-suggested agents, vancomycin and metronidazole.
Hospital Mattresses: A Vector for Spreading <i>Clostridium difficile</i>
At the 5th annual international C. diff Awareness Conference and Health Expo, Dr. Edmond Hooker discussed an underreported problem in health care facilities everywhere.
Common Food Additive Linked with Increased Virulence of <em>C. difficile</em>
Investigators from the Baylor College of Medicine in Houston, Texas, have discovered that a common food additive, trehalose (an artificial sugar frequently derived from mushrooms or seaweed), can be linked with the increase and severity of outbreaks involving 2 strains of Clostridium difficile.
Nurses Can Play a Bigger Role in Antibiotic Stewardship Programs
A recent webinar hosted by the Centers for Disease Control and Prevention and nursing organizations highlighted the important role of nurses in implementing hospital antibiotic stewardship programs.
Contemplating Regulatory Frameworks for FMT
Authors of a new Policy Forum suggest an alternative approach to regulating fecal microbiota transplantation.
Current Understanding of the Dominant Strains of <i>Clostridium difficile</i>
Panelists Peter L. Salgo, MD; Dale N. Gerding, MD; Daniel E. Freedberg, MD, MS; Yoav Golan, MD, MS; Erik Dubberke, MD; and Lawrence J. Brandt, MD, classify the various strains of Clostridium difficile and the factors that differentiate each type and discuss patients’ resistance to commonly prescribed antibiotics for the infection.
FEATURED
Big advances in treatment can